Burkitt lymphoma (BL) is classified as a poorly differentiated lymphocytic lymphoma of B lymphocytes. It mainly affects children. It is one of the rapidly growing tumors in humans, with profuse proliferation. It is a rare malignancy comprised of only 0.76% of solid malignant tumors among Indian children.
INTRODUCTION
Burkitt lymphoma is a rare highly aggressive lymphoma firstly identified and described by Denis Parsons Burkitt, a surgeon in 1958 in Africa, areas which are endemic for malaria. Histological similarity was found between BL occurring in nonendemic areas and in endemic areas. 1 In 1982, the c-myc gene was found showing abnormal production of B lymphocytes. This gene showed translocation between long arms of chromosome 8 with 14 and, to a lesser extent, between chromosomes 8, 22, and 2. 2 There are three subtypes of BL. The endemic variant (African type) is strongly linked with EBV. Patient presents with involvement of jaw, facial bones (orbit), cervical lymph nodes, distal ileum, cecum, ovaries, kidney, breast, and skeletal. 3 The sporadic type (non-African) is sometimes associated with EBV. Patient presents with abdominal tumors associated with bone marrow affection, bowel obstruction secondary to ileocecal intussusception due to tumor growth. Generalized lymphadenopathy is rare. Immunodeficiency-related BL associated with human immunodeficiency virus infection presents with nodal and bone marrow involvement. 4 
CASE REPORT
We report a case of a 7-year-old Indian girl, referred to the Department of Pathology, J.J.M Medical College, presenting with complaints of abdominal pain and distention since 15 days. On physical examination, she was afebrile, respiratory rate was 25/min, pulse rate of 94/min, and blood pressure was 90/60 mm Hg.
On systemic examination, cardiovascular system, respiratory system, and central nervous system (CNS) were normal. On per-abdomen examination, the abdomen was soft, nontender, all quadrants did not move equally well with respiration, and a mass per abdomen was palpated measuring 10 × 2 cm around the umbilicus; there was no fluid thrill and normal bowel sounds were present. On investigating, her complete hemogram showed hemoglobin of 9.8 gm%, total leukocyte count of 12,270 cells/ cumm, platelet count of 4.35 lakhs/cumm, and peripheral smear showed microcytic hypochromic anemia.
At the time of examining the peripheral smear, there was no evidence of spillage of lymphoma cells in circulating blood. Other parameters done were lactate dehydrogenase (LDH), which was elevated to 2,594 IU/L, and alpha-fetoprotein was normal: 2 ng/mL. Ultrasonography (USG) of abdomen and pelvis revealed two cystic lesions, one measuring 7 × 6 × 2 cm with altered internal echoes in the central abdomen and the other clear cystic lesion in pelvis measuring 8 × 4 × 3 cm (Probable diagnosis mesenteric cysts). For further evaluation, computed tomography of abdomen and pelvis was done which confirmed the USG findings (well-defined cystic lesion in midline in pelvis measuring 6.2 × 3.8 × 8 cm, a fat density solid component noted within the cystic lesion measuring 1 × 1 × 0.8 cm; uterus and ovaries were not seen separately) (Fig. 1) .
Laparotomy was done. Intraoperatively, right and left ovaries were found to be enlarged which were firm in consistency measuring 3 × 3 and 6 × 4 cm respectively. A hard mass with multiple lymph node enlargement was found in the mesentery of the distal ileum.
Scrape and imprint smears of both ovaries and abdominal lymph nodes were taken intraoperatively. Subsequently, lymph node biopsy of both ovaries and IJRSMS omental specimens was sent for histopathology study, and peritoneal fluid was sent for fluid cytology analysis. Bone marrow aspirate was also performed intraoperatively. Scrape, imprint cytology, biopsy of all specimens, and bone marrow aspirate showed features which were suggestive of non-Hodgkin lymphoma-Burkitt type.
Lymph node biopsy showed effaced architecture replaced by sheets of intermediate-sized cells having high nuclear-cytoplasmic ratio, open chromatin, few nucleoli and increased mitotic activity, and areas of apoptosis with a classical starry sky appearance (Fig. 2) . Similar features were seen on ovarian and omental tissue (Figs 3 to 8) . Immunohistochemical markers performed for CD20 was positive and negative for CD3, confirming that it was a B-cell lymphoma (Figs 9 to 12 ). Based on the clinical, hematologic, radiographic, cytomorphology, histopathology, and immunohistochemical investigations, the final diagnosis of BL was considered.
DISCUSSION
Burkitt lymphoma is defined by the updated World Health Organization classification as the high-grade aggressive B-cell lymphoma. 5 It is a rapidly growing human tumor with a doubling time of less than 24 hours. 6 This tumor accounts for more than 50% of all childhood cancers in Africa. 
IJRSMS
In non-African countries, it accounts for less than 2% of all cases of NHL. Isolated cases of BL are reported intermittently from all over India. However, very few large related studies have been done in children and young adults. From the available report by Naresh et al, 7 out of 2,773 lymphoma cases, 50 cases, i.e., 1.8%, were of BL. i.e., 1.8%, were of BL. 6 In order to know the true incidence of BL in Indian children and young adults, a large study needs to be undertaken. The role of EBV in BL is not well understood. This virus preferentially infects B-cells via the C3d complement receptor CD2. 5 In Africa, BL usually presents in the jaw, whereas sporadic BL presents as abdominal mass. However, in India, clinical presentation of BL is intermediate between the sporadic and endemic types. In a study conducted by VP Choudhary et al, 8 they found that BL in India presents with equal involvement of jaw and abdomen in almost equal number and concluded that it is the third mode of clinical presentation. A separate staging system for BL has been developed by Zeigler (1981) , whereas Levine et al (1982) classified the cases of the American BL as follows 9 :
• Based on the staging proposed by Levine et al, the present case can be grouped as stage IV, as there is a bone marrow involvement. Patients with any of the above three clinical variants are at higher risk for spread to the CNS and bone marrow. The bone marrow is positive in 30 to 38%, and the CNS is involved in 13 to 17% of adult cases. 1 In a study of children with disseminated disease, 12% had CNS involvement, and 22% had marrow involvement. 10 The most important prognostic features for BL are yet to be found, but some features that have been associated with adverse outcome in adults and children include more age, advanced stage, poor performance status, bulky disease, and high LDH, and CNS or marrow involvement has poor prognosis. Among pediatric patients, a poorer prognosis is associated with age over 15 years.
11
The closest differential diagnosis of BL is diffuse large B-cell lymphoma. There is no single test or marker which can differentiate between these two lymphomas. Hence, various approaches are required which include cytomorphological findings, IHC/biopsy with IHC, genetic studies, and clinical correlation to differentiate and establish a diagnosis of BL. Intermediate-sized cells with clumped chromatin, and two to three prominent nucleoli, cytoplasmic vacuolation, and scattered tingible body macrophages form characteristic cytomorphology of BL. Prototypical immunophenotype of BL includes CD20+, CD10+, BCL6+, BCL2−, TdT−, and sIgM+ with virtually all cells Ki-67+. 12 Immunophenotypic analysis in the present case showed neoplastic cells positive for CD20 and negative for CD3.
CONCLUSION
Burkitt lymphoma is a very rare, fast-progressing malignant tumor of childhood with diverse clinical features. Although it occurs infrequently among Indian population, it does not mean that it should deter the clinician from including it as a part of differential diagnosis. Hence, our findings suggested and emphasized that BL must be suspected in differential diagnosis of a child presenting with large intra-abdominal mass and histological diagnosis should be established as soon as possible along with the IHC markers for confirmation of the diagnosis.
